Physician profile
Ira Spinner
NPI 1366556136
$954.51
in general payments reported to CMS, 2019-2025
9 companies · $59.55 in 2025
The $59.55 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.39 · 2021: $18.91 · 2022: $237 · 2023: $306 · 2024: $314 · 2025: $59.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $217.16 | 2023-2025 | Stravix, Grafix Pl, Collagenase Santyl |
| Treace Medical Concepts, INC. | $171.42 | 2022-2024 | |
| Organogenesis INC. | $152.69 | 2024 | Apligraf |
| Shockwave Medical, INC | $140.40 | 2022 | |
| Angiodynamics, INC. | $123.23 | 2023 | Auryon Laser System 100-120 Vac |
| Kerecis Limited | $85.18 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $26.13 | 2025 | Activ.A.C. |
| Stryker Corporation | $19.39 | 2020 | |
| Horizon Therapeutics Plc | $18.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ira Spinner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.